Get a free Cisco WebEx Meetings account. 1  Share your presentations, videos, and websites. 2  Enjoy face-to-face meetings with up to. 7 webcams â now in high-definition video. 3  Meet anytime on your smartphone or tablet.
OPANAÂ® ER is an opioid agonist indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. Limitations of Use.
In June 2006, Food and Drug Administration (FDA) approved immediate-release (IR) and extended-release (ER) oxymorphone oral tablets under brand names Opana Â® and Opana ER Â® . Recently generic oxymorphone formulations were approved by FDA. Licit Uses: Oxymorphone is indicated for the relief of moderate to severe pain. It is currently marketed both as immediate release tablets containing 5 mg and 10 mg and as extended release tablets containing 5 mg, 7.5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 40 mg oxymorphone hydrochloride. It is also available as 1 mg/mL injectable formulation.